Jack Stewart discusses SOR-C18 leading the phase 1b clinical trial in pancreatic cancer

Jack Stewart, CSO of Soricimed Biopharma explains SOR-C13 is the leading drug in a phase 1b clinical trial in late stage pancreatic cancer. Author: Cancer-News Added: 08/23/2019
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts